Reade Rheumatology Research Institute Report issue

Academic/Hospital Phase 4
Founded: Amsterdam Netherlands

Organization Overview

First Clinical Trial
2007
NCT00462111
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Reade Rheumatology Research Institute | Sint Maartenskliniek